Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease.

ABSTRACT: At the end of December 2019, a new strain of coronavirus was identified in the Wuhan city of Hubei province in China. Within a shorter period of time, an unprecedented outbreak of this strain was witnessed over the entire Wuhan city. This novel coronavirus strain was later officially renamed as COVID-19 (Coronavirus disease 2019) by the World Health Organization. The mode of transmission was human-to-human contact and hence resulted in a rapid surge across the globe where more than 24 million people have been infected with COVID-19. In the current scenario, finding potent drug candidates for the treatment of COVID-19 has emerged as the most challenging task for clinicians and researchers worldwide. Identification of new drugs and vaccine development may take from a few months to years base

SUBMITTER: Balakrishnan V 

PROVIDER: S-EPMC7521772 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature